🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07520513
Starting soon Not applicable

Socket Shield Technique With CGF and Xenograft for Immediate Implants

NCT07520513 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2026-04-05
Last updated
2026-04-13

Condition(s) studied

Alveolar Bone LossSocket Shield TechniqueBone ResorptionImmediate Dental Implant PlacementConcentrated Growth FactorsXenograftAlveolar Bone Preservation

Investigational drug(s) / intervention(s)

Socket Shield Technique with Immediate Implant Placement and CGF + Xenograft

Socket Shield Technique with Immediate Implant Placement and CGF + Xenograft: The procedure involves partial extraction therapy using the socket shield technique, where the buccal portion of the root is preserved to maintain the alveolar bone. Immediate implant placement is performed into the extraction socket. Concentrated growth factors (CGF) are prepared from the patient's autologous blood via centrifugation and combined with xenograft to form a "sticky bone" graft. This graft is placed in the jumping gap between the implant and socket wall to enhance bone regeneration and healing. Implant stability will be measured using resonance frequency analysis (Osstell), and radiographic evaluation will be performed using CBCT.

Study summary

This prospective case series aims to evaluate the clinical and radiographic outcomes of immediate implant placement using the socket shield technique combined with concentrated growth factors (CGF) and xenograft in the esthetic zone. The study will assess crestal bone level changes and implant stability over a 6-month follow-up period.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion criteria: * Age ≥18 years old. (Younis, W., \& El-Rashidy, A. 2020). * Both male and female patients. * Maxillary, anterior and premolar segments. Exclusion Criteria: * A medical history that contraindicates oral surgical treatment such as (uncontrolled/untreated diabetes mellitus, immuno-compromised status, radio or chemotherapy of the oral and maxillofacial region, treatment with oral and/or intravenous bisphosphonates). * Presence of active or untreated periodontal disease. * Vertical root fractures involving the buccal aspect. * Tooth /teeth with horizontal fractures below bone level. * Tooth /teeth with external or internal resorption. * Patients with destructive oral habits such as smoking, chewing tobacco, bruxism, etcetera.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Faculty of Dentistry, Cairo University Cairo Cairo Governorate

More Cairo University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07520513 on ClinicalTrials.gov ↗ ← All trials in Egypt